$HRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HERON THERAPEUTICS, INC. /DE/. Get notifications about new insider transactions in HERON THERAPEUTICS, INC. /DE/ for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Option Exercise | M | 9.05 | 16,292 | 147,443 | 0 | |
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Option Exercise | M | 8.80 | 5,250 | 46,200 | 0 | |
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Sell | S | 15.33 | 21,542 | 330,263 | 0 | 21.5 K to 0 (-100.00 %) |
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Buy | M | 9.05 | 16,292 | 147,443 | 21,542 | 5.3 K to 21.5 K (+310.32 %) |
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Buy | M | 8.80 | 5,250 | 46,200 | 5,250 | 0 to 5.3 K |
| Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 15.30 | 130,000 | 1,989,000 | 130,000 | |
| Apr 07 2017 | HRTX | HERON THERAPEUTICS ... | Christian Waage | Director | Option Exercise | A | 13.50 | 1,125 | 15,188 | 1,125 | |
| Jan 23 2017 | HRTX | HERON THERAPEUTICS ... | POYHONEN JOHN | Director | Buy | P | 12.20 | 10,000 | 122,000 | 10,000 | 0 to 10 K |
| Jan 23 2017 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 12.20 | 2,459,016 | 29,999,995 | 8,332,907 | 5.9 M to 8.3 M (+41.86 %) |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Christian Waage | Director | Option Exercise | A | 13.00 | 15,500 | 201,500 | 15,500 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | POYHONEN JOHN | Director | Option Exercise | A | 13.00 | 19,500 | 253,500 | 19,500 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Johnson Craig A | Director | Option Exercise | A | 13.00 | 21,000 | 273,000 | 21,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | A | 13.00 | 310,000 | 4,030,000 | 310,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 13.00 | 310,000 | 4,030,000 | 310,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 13.00 | 17,000 | 221,000 | 17,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Option Exercise | A | 13.00 | 120,000 | 1,560,000 | 120,000 | |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 12.62 | 538 | 6,791 | 3,798 | 3.3 K to 3.8 K (+16.50 %) |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 18.22 | 577 | 10,515 | 3,260 | 2.7 K to 3.3 K (+21.51 %) |
| Oct 07 2016 | HRTX | HERON THERAPEUTICS ... | Johnson Craig A | Director | Option Exercise | A | 16.83 | 50,000 | 841,500 | 50,000 | |
| Aug 12 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President & CCO | Option Exercise | M | 7.20 | 100,000 | 720,000 | 825,000 | |
| Aug 12 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President & CCO | Sell | S | 23.89 | 12,400 | 296,278 | 2,640 | 15 K to 2.6 K (-82.45 %) |
| Aug 12 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President & CCO | Sell | S | 23.21 | 87,600 | 2,033,616 | 15,040 | 102.6 K to 15 K (-85.35 %) |
| Aug 12 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President & CCO | Buy | M | 7.20 | 100,000 | 720,000 | 102,640 | 2.6 K to 102.6 K (+3,787.88 %) |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 4,630 | 33,336 | 930,277 | |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 4,630 | 33,336 | 66,309 | 61.7 K to 66.3 K (+7.51 %) |
| Jul 20 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 18.22 | 837 | 15,253 | 61,679 | 60.8 K to 61.7 K (+1.38 %) |
| Jun 23 2016 | HRTX | HERON THERAPEUTICS ... | Johnson Craig A | Director | Option Exercise | A | 17.89 | 1,000 | 17,890 | 1,000 | |
| Jun 23 2016 | HRTX | HERON THERAPEUTICS ... | Christian Waage | Director | Option Exercise | A | 17.89 | 1,500 | 26,835 | 1,500 | |
| Jun 23 2016 | HRTX | HERON THERAPEUTICS ... | Christian Waage | Director | Option Exercise | A | 17.89 | 25,000 | 447,250 | 25,000 | |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | M | 3.60 | 1,250,000 | 4,500,000 | 0 | |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Payment of Exercise | F | 18.47 | 243,639 | 4,500,012 | 5,873,891 | 6.1 M to 5.9 M (-3.98 %) |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | M | 3.60 | 1,250,000 | 4,500,000 | 6,117,530 | 4.9 M to 6.1 M (+25.68 %) |
| Mar 23 2016 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Option Exercise | M | 9.05 | 1,100 | 9,955 | 42,800 | |
| Mar 23 2016 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Buy | M | 9.05 | 1,100 | 9,955 | 2,200 | 1.1 K to 2.2 K (+100.00 %) |
| Mar 03 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 3,472 | 24,998 | 934,907 | |
| Mar 03 2016 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 3,472 | 24,998 | 60,842 | 57.4 K to 60.8 K (+6.05 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | M | 7.20 | 19,662 | 141,566 | 925,000 | |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | M | 7.20 | 4,010 | 28,872 | 944,662 | |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | M | 7.20 | 176,328 | 1,269,562 | 948,672 | |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 22.15 | 19,662 | 435,433 | 2,640 | 22.3 K to 2.6 K (-88.16 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Buy | M | 7.20 | 19,662 | 141,566 | 22,302 | 2.6 K to 22.3 K (+744.77 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 22.19 | 4,010 | 88,967 | 2,640 | 6.7 K to 2.6 K (-60.30 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Buy | M | 7.20 | 4,010 | 28,872 | 6,650 | 2.6 K to 6.7 K (+151.89 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 25.11 | 6,230 | 156,438 | 2,640 | 8.9 K to 2.6 K (-70.24 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 24.49 | 32,224 | 789,037 | 8,870 | 41.1 K to 8.9 K (-78.42 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 23.47 | 76,949 | 1,805,955 | 41,094 | 118 K to 41.1 K (-65.19 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Sell | S | 22.50 | 60,925 | 1,370,593 | 118,043 | 179 K to 118 K (-34.04 %) |
| Apr 21 2016 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Buy | M | 7.20 | 176,328 | 1,269,562 | 178,968 | 2.6 K to 179 K (+6,679.09 %) |
| Jan 29 2016 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Executive VP, Drug ... | Option Exercise | A | 20.69 | 300,000 | 6,207,000 | 300,000 | |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Option Exercise | M | 9.05 | 1,100 | 9,955 | 43,900 | |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Buy | M | 9.05 | 1,100 | 9,955 | 1,100 | 0 to 1.1 K |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 2,315 | 16,668 | 938,379 | |
| Dec 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 2,315 | 16,668 | 82,370 | 80.1 K to 82.4 K (+2.89 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 29.41 | 17,000 | 499,970 | 17,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | POYHONEN JOHN | Director | Option Exercise | A | 29.41 | 19,500 | 573,495 | 19,500 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Option Exercise | A | 29.41 | 19,000 | 558,790 | 19,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Johnson Craig A | Director | Option Exercise | A | 29.41 | 19,000 | 558,790 | 19,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | A | 29.41 | 250,000 | 7,352,500 | 250,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 29.41 | 250,000 | 7,352,500 | 250,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Option Exercise | A | 29.41 | 50,000 | 1,470,500 | 50,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Option Exercise | A | 29.41 | 50,000 | 1,470,500 | 50,000 | |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 9.36 | 714 | 6,682 | 2,683 | 2 K to 2.7 K (+36.26 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 7.60 | 1,151 | 8,746 | 1,969 | 818 to 2 K (+140.71 %) |
| Oct 15 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 10,000 | 72,000 | 940,694 | |
| Oct 15 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 10,000 | 72,000 | 80,055 | 70.1 K to 80.1 K (+14.27 %) |
| Oct 13 2015 | HRTX | HERON THERAPEUTICS ... | Clendeninn Neil James | SVP & Chief Medical ... | Option Exercise | A | 28.30 | 50,000 | 1,415,000 | 50,000 | |
| Oct 13 2015 | HRTX | HERON THERAPEUTICS ... | Clendeninn Neil James | SVP & Chief Medical ... | Option Exercise | A | 28.30 | 100,000 | 2,830,000 | 100,000 | |
| Sep 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 14,306 | 103,003 | 950,694 | |
| Sep 30 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 14,306 | 103,003 | 70,055 | 55.7 K to 70.1 K (+25.66 %) |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | M | 7.20 | 10,000 | 72,000 | 965,000 | |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | M | 7.20 | 10,000 | 72,000 | 55,749 | 45.7 K to 55.7 K (+21.86 %) |
| Aug 19 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 7.60 | 2,881 | 21,896 | 45,749 | 42.9 K to 45.7 K (+6.72 %) |
| Jun 12 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 24.75 | 121,212 | 2,999,997 | 4,867,530 | 4.7 M to 4.9 M (+2.55 %) |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Option Exercise | M | 8.80 | 10,500 | 92,400 | 21,000 | |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Option Exercise | M | 9.05 | 2,708 | 24,507 | 16,292 | |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Sell | S | 23.58 | 10,500 | 247,590 | 0 | 10.5 K to 0 (-100.00 %) |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Buy | M | 8.80 | 10,500 | 92,400 | 10,500 | 0 to 10.5 K |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Sell | S | 21.17 | 2,708 | 57,328 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 03 2015 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Buy | M | 9.05 | 2,708 | 24,507 | 2,708 | 0 to 2.7 K |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 23.84 | 32,395 | 772,294 | 4,746,318 | 4.7 M to 4.7 M (+0.69 %) |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.30 | 2,380 | 45,934 | 4,713,923 | 4.7 M to 4.7 M (+0.05 %) |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.74 | 115,225 | 2,274,058 | 4,711,543 | 4.6 M to 4.7 M (+2.51 %) |
| Mar 09 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Option Exercise | M | 9.40 | 70,000 | 658,000 | 140,000 | |
| Mar 09 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Sell | S | 15.40 | 20,000 | 308,000 | 0 | 20 K to 0 (-100.00 %) |
| Mar 09 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Sell | S | 14.40 | 50,000 | 720,000 | 20,000 | 70 K to 20 K (-71.43 %) |
| Mar 09 2015 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Buy | M | 9.40 | 70,000 | 658,000 | 70,000 | 0 to 70 K |
| Mar 04 2015 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Sell | S | 13.07 | 10,000 | 130,727 | 42,868 | 52.9 K to 42.9 K (-18.92 %) |
| Dec 16 2014 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 9.05 | 17,000 | 153,850 | 17,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | A | 9.05 | 300,000 | 2,715,000 | 300,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 9.05 | 300,000 | 2,715,000 | 300,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 52,868 | 62.9 K to 52.9 K (-15.91 %) |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Gift | G | 0.00 | 928 | 0 | 62,868 | 63.8 K to 62.9 K (-1.45 %) |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | J | 7.50 | 1,941 | 14,552 | 63,796 | 61.9 K to 63.8 K (+3.14 %) |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Marshall Paul | SVP, Technical Oper ... | Option Exercise | A | 9.05 | 45,000 | 407,250 | 45,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Gelder Mark S. MD | SVP & Chief Medical ... | Option Exercise | A | 9.05 | 45,000 | 407,250 | 45,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Option Exercise | A | 9.05 | 35,000 | 316,750 | 35,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Drazba Brian G. | VP, Finance & CFO | Buy | J | 7.50 | 818 | 6,133 | 818 | 0 to 818 |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | POYHONEN JOHN | Director | Option Exercise | A | 9.05 | 19,500 | 176,475 | 19,500 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | MANHARD KIMBERLY | Director | Option Exercise | A | 9.05 | 19,000 | 171,950 | 19,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | Johnson Craig A | Director | Option Exercise | A | 9.05 | 19,000 | 171,950 | 19,000 | |
| Dec 15 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 9.05 | 12,500 | 113,125 | 12,500 | |
| Sep 30 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | M | 7.20 | 120,313 | 866,254 | 0 | |
| Sep 30 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Payment of Exercise | F | 8.44 | 102,634 | 866,231 | 20,076 | 122.7 K to 20.1 K (-83.64 %) |
| Sep 30 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Buy | M | 7.20 | 120,313 | 866,254 | 122,710 | 2.4 K to 122.7 K (+5,019.32 %) |
| Sep 05 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 9.49 | 25,000 | 237,250 | 25,000 | |
| Jun 27 2014 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 11.75 | 510,638 | 5,999,997 | 4,596,318 | 4.1 M to 4.6 M (+12.50 %) |
| Jun 26 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | P | 11.75 | 10,000 | 117,500 | 61,855 | 51.9 K to 61.9 K (+19.28 %) |
| Jan 14 2014 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 8.81 | 27,750 | 244,367 | 27,750 | |
| Mar 28 2014 | HRTX | HERON THERAPEUTICS ... | Gelder Mark S. MD | SVP & Chief Medical ... | Option Exercise | A | 15.18 | 100,000 | 1,518,000 | 100,000 | |
| Jan 07 2014 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 0.45 | 2,733,333 | 1,230,000 | 2,733,333 | |
| Jan 07 2014 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | A | 0.45 | 3,400,000 | 1,530,000 | 3,400,000 | |
| Jan 07 2014 | HRTX | HERON THERAPEUTICS ... | Gelder Mark S. MD | SVP & Chief Medical ... | Option Exercise | A | 0.45 | 1,600,000 | 720,000 | 1,600,000 | |
| Jan 07 2014 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Chief Operating Off ... | Option Exercise | A | 0.45 | 1,066,667 | 480,000 | 1,066,667 | |
| Nov 22 2013 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.40 | 17,500,000 | 7,000,000 | 81,713,600 | 64.2 M to 81.7 M (+27.25 %) |
| Nov 21 2013 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Buy | P | 0.40 | 1,000,000 | 400,000 | 1,037,100 | 37.1 K to 1 M (+2,695.42 %) |
| Jul 19 2013 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Option Exercise | M | 0.26 | 254,088 | 66,063 | 393,366 | |
| Jul 19 2013 | HRTX | HERON THERAPEUTICS ... | Whelan John | CFO | Buy | M | 0.26 | 254,088 | 66,063 | 254,088 | 0 to 254.1 K |
| May 03 2013 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | President | Option Exercise | A | 0.36 | 22,500,000 | 8,100,000 | 22,500,000 | |
| May 03 2013 | HRTX | HERON THERAPEUTICS ... | Quart Barry D | Chief Executive Off ... | Option Exercise | A | 0.36 | 22,500,000 | 8,100,000 | 22,500,000 | |
| May 03 2013 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Chief Operating Off ... | Option Exercise | A | 0.36 | 11,000,000 | 3,960,000 | 11,000,000 | |
| May 03 2013 | HRTX | HERON THERAPEUTICS ... | Gelder Mark S. MD | SVP & Chief Medical ... | Option Exercise | A | 0.36 | 2,000,000 | 720,000 | 2,000,000 | |
| Feb 12 2013 | HRTX | HERON THERAPEUTICS ... | ADAM MICHAEL A | Chief Operating Off ... | Option Exercise | A | 0.75 | 1,000,000 | 750,000 | 1,000,000 | |
| Feb 12 2013 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | SVP & Chief Commerc ... | Option Exercise | A | 0.75 | 350,000 | 262,500 | 350,000 | |
| Feb 12 2013 | HRTX | HERON THERAPEUTICS ... | Whelan John | President, CEO and ... | Option Exercise | A | 0.75 | 1,750,000 | 1,312,500 | 1,750,000 | |
| Feb 12 2013 | HRTX | HERON THERAPEUTICS ... | Gelder Mark S. MD | SVP & Chief Medical ... | Option Exercise | A | 0.75 | 75,000 | 56,250 | 75,000 | |
| Oct 17 2012 | HRTX | HERON THERAPEUTICS ... | Rosen Robert | SVP & Chief Commerc ... | Option Exercise | A | 0.62 | 10,000,000 | 6,200,000 | 10,000,000 | |
| Sep 12 2012 | HRTX | HERON THERAPEUTICS ... | SPCH, LLLP | 10% Owner | Buy | P | 0.53 | 38,095,238 | 20,000,000 | 38,095,238 | 0 to 38.1 M |
| Jul 27 2012 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.53 | 9,523,810 | 5,000,000 | 69,960,316 | 60.4 M to 70 M (+15.76 %) |
| May 31 2012 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 0.58 | 500,000 | 290,000 | 500,000 | |
| May 31 2012 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 0.58 | 500,000 | 290,000 | 500,000 | |
| May 31 2012 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 0.58 | 500,000 | 290,000 | 500,000 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 0.26 | 400,000 | 104,000 | 400,000 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | ADAM MICHAEL A | COO | Option Exercise | A | 0.26 | 9,798,150 | 2,547,519 | 9,798,150 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | ADAM MICHAEL A | COO | Option Exercise | A | 0.26 | 1,851,850 | 481,481 | 1,851,850 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | Whelan John | President, CEO & CF ... | Option Exercise | A | 0.26 | 24,902,546 | 6,474,662 | 24,902,546 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | Whelan John | President, CEO & CF ... | Option Exercise | A | 0.26 | 647,454 | 168,338 | 647,454 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | GODDARD PAUL | Director | Option Exercise | A | 0.26 | 400,000 | 104,000 | 400,000 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 0.26 | 6,322,303 | 1,643,799 | 6,322,303 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | BARR JOHN | Vice President of R ... | Option Exercise | A | 0.26 | 677,697 | 176,201 | 677,697 | |
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | TURNBULL GREG | Director | Option Exercise | A | 0.26 | 400,000 | 104,000 | 400,000 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 1,000.00 | 600 | 600,000 | 589,200 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.04 | 300 | 12 | 294,600 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 1,786 | 0 | 5,266,568 | 5.3 M to 5.3 M (+0.03 %) |
| Jul 01 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 0.18 | 25,000,000 | 4,500,000 | 25,000,000 | |
| Jul 01 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.15 | 50,000,000 | 7,500,000 | 60,436,506 | 10.4 M to 60.4 M (+479.09 %) |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | J | 1,000.00 | 600 | 600,000 | 0 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | J | 0.04 | 300 | 12 | 0 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 1,786 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 1,000.00 | 600 | 600,000 | 600 | |
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 0.04 | 300 | 12 | 300 |